Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab. (2021)
Attributed to:
King's Health Partners Confidence in Concept
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/jitc-2021-002742
PubMed Identifier: 34233964
Publication URI: http://europepmc.org/abstract/MED/34233964
Type: Journal Article/Review
Volume: 9
Parent Publication: Journal for immunotherapy of cancer
Issue: 7
ISSN: 2051-1426